Sunfox Technologies has secured Rs 15 crore in a pre-Series A funding round led by Venture Catalysts along with participation from Finvolve through the IA Growth Opportunities Fund I and Brew Opportunities Fund, as well as Universal Group, RP Singhvi Group, and others.
Founded in 2016 by Rajat Jain, Arpit Jain, Saurabh Badola, Nitin Chandola, and Sabit Rawat, Sunfox is an R&D lab which aims to develop cutting-edge healthcare technologies for the digital world. Its flagship product Spandan is a smartphone-based portable ECG device that provides clinically accurate 12-lead ECG readings, empowering users to detect heart attacks and monitor cardiac health in real-time.
Dehradun-based claims that Spandan has been used by over 30,000 individuals across 20 countries and saved more than 10,000 lives through early detection of heart conditions. This technology is proving critical as India confronts a surge in heart attacks post-COVID-19.
Sunfox has established an advanced in-house R&D and manufacturing facility in Dehradun and even captured global attention from prestigious institutions such as Oxford and Wharton.